Elicio Total Assets from 2010 to 2024

ELTX Stock

4.88 0.20 3.94%

Elicio Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 20.5 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

27.1 M

Current Value

20.5 M

Quarterly Volatility

6.4 M

Credit Downgrade

Yuan Drop

Covid

Check Elicio Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elicio Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 391.6 K, Depreciation And Amortization of 828.2 K or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 0.57, Dividend Yield of 0.0 or PTB Ratio of 3.89. Elicio financial statements analysis is a perfect complement when working with Elicio Therapeutics Valuation or Volatility modules.

Check out the analysis of Elicio Therapeutics Correlation against competitors.

For more information on how to buy Elicio Stock please use our How to Invest in Elicio Therapeutics guide.

Latest Elicio Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Elicio Therapeutics over the last few years. Total assets refers to the total amount of Elicio Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Elicio Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Elicio Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elicio Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 27.15 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Elicio Total Assets Regression Statistics

	Arithmetic Mean	12,875,373
	Geometric Mean	11,707,989
	Coefficient Of Variation	49.58
	Mean Deviation	5,386,290
	Median	8,835,655
	Standard Deviation	6,383,154
	Sample Variance	40.7T
	Range	18.3M
	R-Value	0.79
	Mean Square Error	16.3T
	R-Squared	0.63
	Significance	0.0004
	Slope	1,132,000
	Total Sum of Squares	570.4T

Elicio Total Assets History

	2024	20.5 M
	2023	27.1 M
	2022	22.7 M
	2021	14.8 M
	2020	19.7 M

Other Fundumenentals of Elicio Therapeutics

Intangibles To Total Assets

Elicio Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Short Long Term Debt
Total Assets		0.08	-0.91	0.62	0.08	-0.92	0.97	0.44	0.18	0.09	0.93	0.79	0.07	0.13	0.79	0.83	-0.59
Total Stockholder Equity	0.08		0.03	-0.34	-0.49	-0.24	0.16	-0.11	-0.97	0.99	0.23	-0.38	0.42	-0.36	-0.38	0.3	-0.67
Net Tangible Assets	-0.91	0.03		-0.82	-0.42	0.96	-0.91	-0.14	-0.28	0.0	-0.74	-0.86	0.21	-0.3	-0.86	-0.88	0.65
Current Deferred Revenue	0.62	-0.34	-0.82		0.73	-0.7	0.64	-0.01	0.5	-0.26	0.46	0.86	-0.72	0.78	0.86	0.49	-0.31
Net Debt	0.08	-0.49	-0.42	0.73		-0.27	0.18	-0.6	0.51	-0.44	-0.2	0.39	-0.85	0.6	0.39	0.21	0.07
Retained Earnings	-0.92	-0.24	0.96	-0.7	-0.27		-0.95	-0.11	-0.01	-0.26	-0.8	-0.73	0.09	-0.2	-0.73	-0.94	0.79
Accounts Payable	0.97	0.16	-0.91	0.64	0.18	-0.95		0.25	0.09	0.18	0.87	0.71	-0.02	0.16	0.71	0.86	-0.61
Net Receivables	0.44	-0.11	-0.14	-0.01	-0.6	-0.11	0.25		0.22	-0.12	0.65	0.43	0.42	-0.01	0.43	-0.02	-0.01
Total Liab	0.18	-0.97	-0.28	0.5	0.51	-0.01	0.09	0.22		-0.96	0.01	0.59	-0.4	0.39	0.59	-0.07	0.49
Net Invested Capital	0.09	0.99	0.0	-0.26	-0.44	-0.26	0.18	-0.12	-0.96		0.25	-0.33	0.33	-0.26	-0.33	0.29	-0.69
Total Current Assets	0.93	0.23	-0.74	0.46	-0.2	-0.8	0.87	0.65	0.01	0.25		0.7	0.19	0.14	0.7	0.66	-0.59
Capital Stock	0.79	-0.38	-0.86	0.86	0.39	-0.73	0.71	0.43	0.59	-0.33	0.7		-0.34	0.54	1.0	0.55	-0.35
Net Working Capital	0.07	0.42	0.21	-0.72	-0.85	0.09	-0.02	0.42	-0.4	0.33	0.19	-0.34		-0.9	-0.34	0.12	-0.16
Short Term Debt	0.13	-0.36	-0.3	0.78	0.6	-0.2	0.16	-0.01	0.39	-0.26	0.14	0.54	-0.9		0.54	-0.11	0.05
Common Stock	0.79	-0.38	-0.86	0.86	0.39	-0.73	0.71	0.43	0.59	-0.33	0.7	1.0	-0.34	0.54		0.55	-0.35
Property Plant Equipment	0.83	0.3	-0.88	0.49	0.21	-0.94	0.86	-0.02	-0.07	0.29	0.66	0.55	0.12	-0.11	0.55		-0.8
Short Long Term Debt	-0.59	-0.67	0.65	-0.31	0.07	0.79	-0.61	-0.01	0.49	-0.69	-0.59	-0.35	-0.16	0.05	-0.35	-0.8

Click cells to compare fundamentals

About Elicio Therapeutics Financial Statements

Elicio Therapeutics investors use historical fundamental indicators, such as Elicio Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elicio Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	27.1 M	20.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Elicio Stock Analysis

When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC